Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 28, 2015; 21(36): 10348-10357
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10348
Laparoscopic sleeve gastrectomy and gastroesophageal reflux
Fabien Stenard, Antonio Iannelli
Fabien Stenard, Digestive and Oncology Unit, Mutualiste Hospital, F-38000 Grenoble, France
Antonio Iannelli, Digestive Unit, Archet 2 Hospital, University Hospital of Nice, F-06202 Nice, France
Antonio Iannelli, Inserm, U1065, Team 8 “Hepatic complications of obesity”, F-06204 Nice, France
Antonio Iannelli, University of Nice Sophia-Antipolis, F-06107 Nice, France
Author contributions: Stenard F and Iannelli A performed the research and helped write the paper.
Conflict-of-interest statement: The authors have no conflicts of interest to declare for this paper.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Correspondence to: Fabien Stenard, MD, PhD, Digestive and Oncology Unit, Mutualiste Hospital, Groupe Hospitalier Mutualiste, 8-10 rue Docteur Calmette, F-38000 Grenoble, France.
Telephone: +33-476707250
Received: March 19, 2015
Peer-review started: March 20, 2015
First decision: May 16, 2015
Revised: June 24, 2015
Accepted: August 28, 2015
Article in press: August 31, 2015
Published online: September 28, 2015


Bariatric surgery is the only effective procedure that provides long-term sustained weight loss. Sleeve gastrectomy (SG) has emerged over the last few years to be an ideal bariatric procedure because it has several advantages compared to more complex bariatric procedures, including avoiding an intestinal bypass. However, several published follow-up studies report an increased rate of gastroesophageal reflux (GERD) after a SG. GERD is described as either de novo or as being caused by aggravation of preexisting symptoms. However, the literature on this topic is ambivalent despite the potentially increased rate of GERDs that may occur after this common bariatric procedure. This article reviews the mechanisms responsible for GERD in obese subjects as well as the results after a SG with respect to GERD. Future directions for clinical research are discussed along with the current surgical options for morbidly obese patients with GERD and undergoing bariatric surgery.

Key Words: Gastroesophageal reflux, Sleeve gastrectomy, Morbid obesity, Bariatric surgery, Gastric bypass

Core tip: Bariatric surgery is the only effective means to sustain weight loss. Sleeve gastrectomy (SG) has become popular because of its advantages over more complex bariatric procedures. However, an increased rate of gastroesophageal reflux (GERD) has been reported after SG that is either de novo or is caused by aggravation of preexisting symptoms. The literature is ambivalent about the implications for increased rates of GERD after SG. This article reviews the mechanisms of GERD in obese subjects, and the results from SG with respect to GERD. Future directions are discussed along with current surgical options for obese patients with GERD and undergoing bariatric surgery.


Obesity is associated with significant morbidity and mortality linked to increased cardiovascular risk, osteoarthritis, diabetes, cancer, and gastroesophageal reflux disease (GERD). Must et al[1] showed, in their cross-sectional study, a general pattern of increased prevalence and severity in overweight and obese subjects. This occurred consistently across all racial and ethnic groups and for all health conditions known to be related to obesity, such as cardiovascular disease, type-2 diabetes mellitus, hypertension, stroke, dyslipidemia, osteoarthritis, and some cancers, with the exception of high blood-cholesterol level.

There is strong published evidence that bariatric surgery is the only effective means to sustain long-term weight loss[2-4]. This weight loss is also associated with the resolution of obesity-related comorbid conditions, which increase the risk of mortality associated with obesity[2-4]. Three main procedures are used nowadays, including gastric banding, Roux-en-Y gastric bypass (LRYGBP), and the more recent sleeve gastrectomy (SG). The latter was introduced more than a decade ago as the first step in a biliopancreatic diversion with a duodenal switch and has, since then, been shown to be effective as a stand-alone bariatric procedure[5,6]. SG has rapidly gained a large consensus worldwide in the bariatric community because of its several advantages, which include it being a simple and straightforward surgical technique without needing an intestinal bypass or causing any digestive anastomosis. This means that the whole digestive tract can be accessed without modifying its anatomy[7].

Although the postoperative mortality and morbidity of SG has been reported to range between those of LRYGBP and gastric banding the results of long-term morbidity are less well known[8]. Schauer et al[9] recently demonstrated the superiority of the RYGB over a SG for the morbidly obese patients with remission type-2 diabetes at 3 years. A recent meta-analysis showed that a RYGBP was significantly more effective than a SG for the remission of obesity-related comorbid conditions, although no significant difference in weight loss was demonstrated[10].

Obesity is associated with an increased risk of GERD, with up to 50% in morbidly obese patients suffering from this condition[11]. It has also been shown that obesity, itself is a risk factor for GERD through its mechanical alterations to the esogastric junction (EGJ), associated with transient relaxation of the lower esophageal sphincter (LES) and/or the presence of a hiatal hernia (HH), which may further exacerbate GERD. Indeed, the latter is considered to be the only independent predictor for GERD. HH impairs the EGJ flap, interfering with transmission of intragastric pressure (IGP) to the LES and modifying its closure. As a consequence, gastric content may reflux into the esophagus. In the obese patient, visceral fat, organomegaly, and elasticity of support core muscles and ligaments are important in generating an elevated IGP during inspiration and expiration, which is responsible, in turn, for increasing the gastroesophageal pressure-gradient during inspiration.

Although GERD can be particularly invalidating and may increase the risk of esophageal adenocarcinoma in the longer term[12,13], the relationship between SG and GERD has not been fully elucidated. As there is no strong evidence regarding the influence of SG on GERD, we reviewed the current literature to determine whether SG could alleviate, cause, or exacerbate GERD.

GERD and obesity

GERD is a disorder of the upper gastrointestinal tract that is defined by heartburn and acid regurgitation, which develops when reflux of the stomach contents cause troublesome symptoms and/or complications, according to the Evidence-Based Consensus of the Montreal Definition and the Classification of Gastroesophageal Reflux Disease, issued in 2006[14]. GERD impacts on the daily life of affected individuals, interfering with physical activity, impairing social functioning, disturbing sleep, and reducing productivity at work.

Different mechanisms are implicated for the occurrence of GERD and reflux esophagitis: i.e., LES at a mediastinal position and/or with a short intra-abdominal length, a low resting LES pressure, transient relaxation of the LES, increased intra-abdominal or intragastric pressure, decreased esophageal clearance, increased acid sensitivity of the esophageal mucosa, and anatomic abnormalities of the EGJ junction, such as HH. Moreover, hormones and nutritional factors, such as fat or alcohol, can influence the resting pressure of the LES.

Obesity may promote GERD by increasing intra-abdominal pressure and the gastroesophageal pressure gradient, as well as inducing mechanical alterations to the EGJ. Pandolfino[15] found a relationship between increasing BMI and the prevalence of GERD, with a high BMI being associated with an elevated risk of GERD. de Vries et al[16] found that increasing BMI was independently associated with increased intragastric pressure (IGP) during inspiration and expiration, which was responsible for an increase in the gastroesophageal-pressure gradient during inspiration. That study also showed that BMI, IGP, and the gastroesophageal-pressure gradient were strong independent predictors for HH, which was the only independent predictor of GERD. Visceral fat, organomegaly, and elasticity of the support core muscles and ligaments also play important roles in generating an elevated IGP. Indeed, not all patients with elevated IGP will develop a HH, and not every patient with a HH will develop GERD. Furthermore, there is no linear correlation with GERD severity.

If the anatomy of the EGJ flap valve is maintained without axial separation of the crura and LES, theoretically an elevation of IGP is transmitted to the intra-abdominal LES, and thus the EGJ remains closed. However, if the EGJ flap valve is obliterated, elevations in IGP may increase the volume of refluxate once the EGJ is forced open. Importantly, esophageal sensitivity varies from one individual to another and abnormal acid exposure is not always associated with GERD symptoms[17]. This may be of major importance when explaining the variability of results reporting on SG and GERD (Table 1).

Table 1 Symptoms of gastroesophageal reflux disease.
GERD in obesityDe novo GERD after SGImprovement of GERD after SG
MechanismIncreasing BMILack of gastric complianceReduced intra-abdominal pressure
Increasing intragastric pressureIncreased intraluminal pressureReduced acid production
Increasing gastroesophageal pressure gradientGastric fundus removalAccelerated gastric emptying
Hiatal herniaLES pressureReduced gastric volume
Final shape of the sleeve
Narrowing at the junction of the vertical and horizontal parts of the sleeve
Twisting of the sleeve
Dilation of the fundus
Persistence of hiatal hernia
Mechanisms involved in de novo GERD after a LSG

Table 1 summarizes the mechanisms involved in de novo GERD after a SG. Some cases are caused by the large compliant stomach being transformed into a long and narrow tube. This implies a lack of gastric compliance, with an increased intraluminal pressure that correlates inversely with the diameter of the gastric tube and is increased when the pylorus is closed. Other factors are related to dismantling of the anatomical antireflux mechanisms, including disruption to the Hiss angle and resection of the sling fibers in the distal part of the lower sphincter, which results in low esophageal-sphincter pressure. The final shape of the sleeve also plays a role as it may favor GERD and regurgitation when it is funnel-shaped. Technical mistakes include narrowing at the junction between the vertical and horizontal parts of the sleeve, twisting of the sleeve[18], anatomical stenosis, and persistence of the gastric fundus and/or a HH that has not been diagnosed before surgery. The role of the gastric antrum has not been fully clarified but it is thought that extensive resection of the antrum may impair gastric empting and favor GERD.

Mechanisms involved in improving GERD after a LSG

Four mains principles seem to explain the improvement of GERD after a SG (Table 1), the decrease in intra-abdominal pressure due to weight loss, reduced acid production related to resection of the acid-producing gastric fundus, accelerated gastric emptying[19,20], and reduced gastric volume. These all contribute to the diminution in gastric refluxate that putatively causes GERD symptoms.


Table 2 summarizes the data obtained from recent literature, which suggest a negative influence of SG on GERD. Thirteen studies included 5953 patients with a mean BMI of 42 ± 4 kg/m2 (range: 37-55.5 kg/m2) and a mean follow up of 29 ± 22 mo (range: 3-72 mo). Of these studies, only one was a prospective randomized study[21]; all the others were retrospective studies reporting on prospectively collected data[22-32]. GERD assessment was based on clinical evaluations that included typical symptoms, such as heartburn, with a few studies using Montreal’s criteria to define GERD.

Table 2 Negative impact of sleeve gastrectomy on gastroesophageal reflux disease.
Ref.Nature of the studyPatients, nPre-operative BMI (kg/m2)GERD evaluationFollow-up (mo)GERD (%) PreopGERD (%) Postop
Himpens et al[21], 2006Prospective randomized: GB vs LSG4039Clinical evaluation36-De Novo
At 1 yr: 21.8%
At 3 yr: 3.1%
Arias et al[23], 2009Retrospective review13043.2NA360De novo: 2.1%
Braghetto et al[25], 2010Retrospective review, and literature review16737 ± 4.4Clinical score: EGD, EM--Increase
Braghetto et al[26], 2010Retrospective review2038.3Clinical score: EM--Increase
Lakdawala et al[27], 2010Retrospective review50--12-Increase
Himpens et al[22], 2010Retrospective review3039.9NA723.30%23%
Carter et al[28], 2011Retrospective review17646.6Clinical evaluation2434.60%47.2%
33.8% (of total) under medication
Howard et al[29], 2011Retrospective review2855.5Clinical evaluation UGICS87 (25%)11 (39%)
De novo: 18%
Soricelli et al[24], 2013Retrospective review: SG + HHR37844 ± 3.5Clinical score: EGD, UGICS, EM. 24-h pH1860/378 (15.8%)71/ 378 (18.7%)
SG: 19/281 (6.7%)SG: 68 (24%)
SG+HHR: 41/97 (42%)SG+HHR: 3/97 (3.1%)
Sieber et al[30], 2014Retrospective review6843 ± 8Clinical evaluation: EGD, UGICS, EM6050%Persistance : 44.1%
De novo: 16%
Gorodner et al[31], 2014Retrospective review. Influence of LSG on GERD1440 ± 6Demeester score: BM, EGD, EM. 24-h pH144 (29%)9 (64%)
Burgerhart et al[32], 2014Prospective study2047.6 ± 6.1RDQ; EM. 24-h pH314 (70%)Persistance: 8 (57%)
Acid exposure: 4.1 %No change: 2 (14%)
Worsening: 6 (43%)
De novo: 10%
Acid exposure: 12%
Dupree et al[33], 2014Retrospective review483247 ± 9Clinical evaluation3644.50%Persistence: 84.1%
De novo: 8.6%
Total: 13 studies

Most studies explored the patients preoperatively using endoscopy; however, the use of esophageal manometry, an upper-gastro-intestinal contrast study, and 24-h pH/impedancemetry were inconsistently reported between the studies. All patients, except for those in the study by Arias et al[23], had preoperative GERD. The data showed a high percentage of persistent preoperative GERD, which occurred in up to 84% of cases in the retrospective review of DuPree et al[33], rather than a true worsening of symptoms. In that study, proton-pump inhibitors (PPIs) were effective against the GERD symptoms.

Conversely, Sheppard et al[34] investigated the incidence of GERD as defined by the use of PPIs after SG and RYGBP in a retrospective series of 387 morbidly obese patients. These authors found that GERD symptoms were significantly increased after SG compared to a RYGB. Interestingly, SG patients required more frequent PPI treatment, indicating the occurrence of de novo GERD in these patients. De novo GERD, which represents the negative impact of this procedure, was found in 2.1%-21% of cases described in Himpens et al[22]’s study. Only one study, from Soricelli et al[24], compared the outcomes of SG by differentiating patients with HH repair from those who had no HH repair during the SG procedure. The authors showed an overall higher postoperative percentage of GERD; nevertheless, they observed a significant decrease in GERD, from 42.1%-3.1% when HH repair was added to the sleeve procedure. These findings underlie the importance of HH and Hiss repair on postoperative GERD independently of the weight-loss effect on GERD.

Table 3 summarizes the studies that reported a favorable impact of SG on GERD. Twelve studies included 1863 patients with a mean BMI of 51 ± 13 kg/m2 (range: 36.5-65 kg/m2) and a mean follow-up of 20 ± 15 mo (range: 6-60 mo)[19,20,35-44]. In these 12 studies, GERD assessment was always based on clinical evaluation without a direct systematic link to the Montreal criteria or the various clinical symptoms. Half of these studies did not include endoscopic assessment, two had data for 24-h pH/impedancemetry, two reported on esophageal manometry, and two had results from a barium meal as the preoperative assessment. All these patients had preoperative GERD.

Table 3 Positive impact of a sleeve gastrectomy on gastroesophageal reflux disease.
Ref.Nature of the studyPatients, nPre-operative BMI (kg/m2)GERD evaluationFollow-up (mo)GERD (%) PreopGERD (%) Postop
Melissas et al[39], 2008Prospective study1449.5CA242 (14%)1 (7%)
Nocca et al[40], 2008Multicenter prospective study16345.9NA2410 (6.1%)6 (3.6%)
Petersen et al[41], 2012Prospective study: 3 groups3750.5 and 47.5CA; EMNANALESP: 8.4 to 21.2 mmHg may protect against GERD
Chopra et al[42], 2012Retrospective review and analysis18549.0CA; EGD6NAImprovement: 46%
De novo: 3.2%
Daes et al[35], 2012Concurrent cohort study13439.0CA; EGD1249.2%1.50%
Rawlins et al[43], 2013Retrospective study5565.0CA; NA6027%27%
53% resolution
16% de novo
Santonicola et al[37], 2013Retrospective comparative180LSG: 36.5CA13-18LSG: 39.2 %LSG: 22.5%, de novo: 17.7%
LSG vs LSG + HHR78 LSGLSG + HHR: 39.3EGDLSG + HHR: 38.4%LSG+HHR: 43.3%, de novo: 22.9%
102 LSG + HHRIf GERD: dc - BM
Sharma et al[19], 2014Prospective study3247.8CDS12CDS: 2.88CDS: 1.63 (P < 0.05)
GERD SSSS: 2.28SS: 1.06 (P < 0.05)
EGDRS: 6.25%RS: 78.1%(P < 0.001)
RSEsophagitis: 18.8%Esophagitis: 25%, reduction of severity
Rebecchi et al[20], 2014Prospective study7144.3GSAS24A:A:
B: NAEBMDemeester: 39.5Demeester: 10.6
24-h pHDemeester: 11.9Demeester: 12
de novo: 5.4%
Pallati et al[38], 2014Prospective database58548.5GERD-symptom grading based on medication use6All patients includedScore improvement 41%
Worsening: 4.6 %
de novo: 9.2%
Del genio et al[44], 2014Prospective database2546.1CA; HRiM, MII-pH13Patient excluded if preop. GERDNo de novo GERD
Retrospective analysis
Daes et al[36], 2014Prospective evaluation38237.7CA2244.5%2.6%
EGD94% resolution of symptoms
Total: 12 studies

Daes et al[36], in their prospective evaluation of 382 patients, showed a 94% resolution of symptoms and emphasized the need for careful attention to surgical technique, such as avoiding relative narrowing at the junction between the vertical and horizontal parts of the stomach, and the importance of placing the anterior stomach wall and posterior stomach wall in an equal and flat position when firing the stapler, in order to keep the sleeve from rolling and spiraling. Interestingly, in the study of Santonicola et al[37], despite a decrease in GERD from 39.2% to 22.5%, there was no difference between pre- and postoperative symptoms after a SG that included or did not include an HH repair. These results emphasize the complex relationship between the mechanisms leading to the occurrence of GERD symptoms and the secondary improvements after weight loss and surgical repair, which increase factors such as the HH. Lastly, a prospective database from Pallati et al[38], which included 585 patients, showed a 41% improvement in GERD symptoms, thus indicating that SG may also suit obese patients suffering from GERD.

Role of a diagnostic work-up (HH, LES dysfunction) and intraoperative exploration

Resting LES pressure has been shown repeatedly to be normal in obese individuals. However, contradictory data exist on the gastroesophageal-pressure gradient. GERD depends on the pressure gradient between the stomach and esophagus. It has been shown that patients with reflux disease have more acid reflux during transient LES relaxation than normal subjects. Transient LES relaxation and HH are both involved in the mechanisms of GERD.

A preoperative diagnostic work-up is helpful when designing a surgical strategy; however, it has been well-demonstrated that the incidence of GERD symptoms in obese subjects does not correlate well with the severity of disease[11]. Suter et al[45] found that 35.8% of morbidly obese patients had symptoms of GERD, of which 53% had HH and 31.4% had peptic esophagitis. Wilson et al[46] showed that there was an association between excess weight, HH, and reflux esophagitis, thus underlying the need for preoperative exploration. However, they also showed that the association between symptoms and disease was poor, with 51% of symptomatic patients not having esophagitis, and 23% of patients with esophagitis not having symptoms.

Furthermore, studying LES dysfunction may not accurately predict GERD symptoms[47], and the incidence of HH is often underestimated by upper gastrointestinal endoscopy and/or a barium meal, which are the procedures currently used by most physicians as the preoperative work-up for morbidly obese patients who are candidates for bariatric surgery. For this reason, some authors suggest the need to assess hiatal crura peroperatively for the presence of a HH[48,49]. Indeed, Soricelli et al[50] showed that “fingerprint” indentation of the diaphragm, just above esophageal emergence, is correlated with the presence of a crural defect. Interestingly, the same author reported that systematic repair of a HH diagnosed at the time of surgical exploration could effectively eliminate de novo GERD after SG[24].


A RYGB is considered the most effective bariatric procedure for GERD symptoms as it limits acid production into the small gastric pouch and reduces esophageal reflux because of the Roux-en Y anatomy, which also retains the physical activity of the esophagus and gastric pouch within the abdomen[51]. Several studies have confirmed that a RYGBP decreases exposure of acid to the esophagus[52-54].

Kim et al[51] showed that conversion of a failed Nissen fundoplication to a RYGB resulted in excellent control of symptoms. Accordingly, Mion et al[54] and Madalosso et al[55] found similar results for a RYGP for GERD. Lastly, De Groot et al[56] compared RYGBP with restrictive procedures, such as gastric banding and vertical-banded gastroplasty, and found better control of symptoms associated with a RYGP. In this study, no data were available for SG as it is a relatively recent procedure.

The role of HH repair appears to be a main concern for some authors at the time of bariatric surgery. Although the need for systematic repair of the crura has only been partially studied for patients undergoing a RYGB[57] this has been more widely investigated in SG surgery.

LSG + HH repair

Studies regarding the outcomes between laparoscopic sleeve gastrectomy (LSG) and HH repair are summarized in Table 4. Santonicola et al[37] showed no improvement of GERD symptoms after concomitant SG and HH repair. Moreover, after bariatric surgery, SG patients with a concomitant HH repair had a significantly higher frequency of heartburn than patients who underwent a LSG alone. In contrast, Soricelli et al[24] reported significant improvement of GERD symptoms after a SG with concomitant HH repair. They described repair of a posterior crura defect with two interrupted non-absorbable sutures, approximating to the right and left diaphragmatic pillars. HH repair was shown to be feasible and safe with no postoperative complications related to this procedure. The authors suggested that approaching the diaphragmatic crus from the left reduced damage to the anterior vascularization of the esogastric junction, which, if it was impaired, could be involved in the development of staple-line leaks after a SG. Furthermore, exposure of the hiatal area to the presence of a HH implies complete freeing of the posterior stomach wall and facilitates complete resection of the gastric fundus. This in turn is of great importance for the success of a SG in terms of weight loss but also avoids de novo GERD caused by acid secretion and regurgitation of the persistent gastric fundus content into the esophagus. In addition, the postoperative development of de novo reflux symptoms was significantly greater in patients who underwent a SG without an HH repair compared to those with an HH repair (22.9% vs 0%, P = 0.01). However, the follow-up for this study was short (12 mo) and midterm results (at the least) are needed before concluding on the role of HH repair.

Table 4 Laparoscopic sleeve gastrectomy and hiatal hernia repair.
No change in GERDImprovement of GERD
Santonicola et al[37], 2014Cuenca-abente et al (case report, no MeSH) 2006
Parikh et al (case report, no MeSH) 2008
Korwar V et al (case report, biological MeSH) 2009
Valera et al (case report, MeSH) 2009
Merchant et al (case report, biologic MeSH) 2009
Soricelli et al[24,50] 2010 (mesh in 2 patients) and 2013 (no MeSH)
Soliman[58] (no mesh, except 2 patients with large HH) 2012
Kotak et al (case report, no MeSH) 2013
Gibson et al[59] (no mesh) 2013 Daes et al[35,36] (no MeSH) 2012 and 2013

Soliman[58] reported favorable results in 20 patients who had concomitant SG and a posterior crural repair. Interestingly, two of the patients with a large HH (> 5 cm) had a polypropylene mesh repair. Thirteen patients reported resolution of GERD symptoms and five reported improvement leading to minimal doses of PPIs at a mean follow-up of 7 mo.

Gibson et al[59] analyzed the results of SG and HH repair in 500 patients. Interestingly, an anterior repair was performed in 265 patients and a posterior repair in 30 patients. The prevalence of GERD was reduced from 45% preoperatively to 6% (n = 30) postoperatively, and postoperative GERD was well controlled in all patients with PPI therapy.

Daes et al[35] 2012 found that concomitant SG and HH repair in 34 of 134 patients undergoing SG resulted in resolution of GERD symptoms in 94% of patients after a mean follow-up of 12 mo. The same author[36] reported on simultaneous SG and HH repair in 142 patients out of 382 undergoing SG, and found that only 8 patients (5.6%) suffered with GERD postoperatively. Of the remaining 240 patients, who did not have a HH intra-operatively, only two developed GERD postoperatively. These data underline the importance of intraoperative exploration of the crural region to detect the presence of a HH, which is often missed at preoperative imaging and endoscopy.

The use of a mesh in HH repair has been described and advocated by authors in non-obese patient[60,61]. Silecchia et al[62] studied the use of absorbable mesh fixed with a non-permanent device in 43 obese patients. Remission of GERD symptoms was observed in 90% of patients, and there were no mesh-related complications at a mean follow up of 17.4 mo; they also reported a 2.3% recurrence rate.


The issue of revisional bariatric surgery has been widely reported in the literature regarding GERD, weight-loss failure, or recurrence[63,64]. Although a RYGBP is the procedure of choice when GERD complicates SG, some considerations should be given before directly converting from a SG to a RYGBP. Cheung et al[64] reported the results from revisional surgery after a SG (Re-SG and RYGBP) and found that both procedures were effective in achieving weight loss following a failed LSG. As weight loss may influence GERD symptoms, a Re-SG may also work as an effective tool to reduce GERD. Indeed, Silecchia et al[65] reported on the safety and efficacy of Re-SG (referred to by the authors as laparoscopic fundectomy) in cases where a residual fundus or neofundus is responsible for GERD symptoms. A Re-SG was done in 19 patients when a residual fundus or neofundus was found in patients with severe GERD symptoms. Of note is that cruroplasty was concomitantly done when a HH was found in this series. All patients had improved GERD symptoms and discontinued PPIs.

Noel et al[66] evaluated 36 patients (34 women and 2 men, mean age 41.3 years, with a BMI of 39.9) after a Re-SG to correct weight-loss failure and intractable severe GERD, related to pouch dilatation, occurring after a primary LSG. The mean interval of time from a primary SG to a ReSG was 34.5 mo (range: 9-67 mo). The ReSG was effective against GERD symptoms in the short term in this series.

HH is not only responsible for GERD but contributes to the incomplete removal of the gastric fundus, which is often missed at the time of a SG. The latter is responsible for acid secretion, which is then regurgitated back into the esophagus, especially if there are other factors such as a HH or an impaired LES, and if increased transient relaxation is present. Thus, Re-SG may be an option for patients with a persistent gastric fundus and or a HH responsible for GERD that is non-responsive to PPIs. However, this procedure should remain limited to patients in whom a relationship between GERD and a persistent gastric fundus is clear, and should be conducted by a specialized bariatric surgeon. If a HH is present, it should be fixed during the same procedure.


SG has become a very popular bariatric procedure in less than a decade because of its several advantages compared to more complicated procedures, including avoiding an intestinal bypass. However, SG as a surgical technique, although straightforward and less technically demanding, implies modification of some of the anatomical antireflux mechanisms. Furthermore, the presence of other factors, such as a HH or an impaired LES, may lead to the appearance of de novo GERD or aggravate a preexisting GERD. Although the extent of this problem is not known because the long-term results for SG beyond 10 years are not yet published, the potential consequences of an increased rate of GERD in the obese is alarming. Indeed, a body of literature shows that both obesity and GERD are responsible for the increased rate of adenocarcinoma of the cardias[67]. Given the number of SGs done annually worldwide this problem should be carefully addressed.

Further randomized studies should address the problem of HH repair in candidates for a SG; the need to diagnose eventual dysfunction of the LES may contraindicate a SG, and thus the extent of a gastric antrum resection. When patients develop GERD after a SG resistant to PPI, a RYGBP remains the operation of choice, whereas some patients with residual fundus after a SG may be suitable candidates for a redo fundectomy or a Re-SG.


The authors thank Dr. Floch and 193 Newmed Publishing Services for the correction of the proofs.


P- Reviewer: Dumitrascu DL, Sinha R S- Editor: Yu J L- Editor: A E- Editor: Wang CH

1.  Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-1529.  [PubMed]  [DOI]
2.  Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, Jacobson P, Lönroth H, Maglio C, Näslund I. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695-704.  [PubMed]  [DOI]
3.  Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.  [PubMed]  [DOI]
4.  Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.  [PubMed]  [DOI]
5.  van Rutte PW, Smulders JF, de Zoete JP, Nienhuijs SW. Outcome of sleeve gastrectomy as a primary bariatric procedure. Br J Surg. 2014;101:661-668.  [PubMed]  [DOI]
6.  Biertho L, Lebel S, Marceau S, Hould FS, Lescelleur O, Marceau P, Biron S. Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases. Dig Surg. 2014;31:48-54.  [PubMed]  [DOI]
7.  Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol. 2008;14:821-827.  [PubMed]  [DOI]
8.  Carlin AM, Zeni TM, English WJ, Hawasli AA, Genaw JA, Krause KR, Schram JL, Kole KL, Finks JF, Birkmeyer JD. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg. 2013;257:791-797.  [PubMed]  [DOI]
9.  Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014;370:2002-2013.  [PubMed]  [DOI]
10.  Li JF, Lai DD, Lin ZH, Jiang TY, Zhang AM, Dai JF. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech. 2014;24:1-11.  [PubMed]  [DOI]
11.  Doulami G, Triantafyllou S, Natoudi M, Albanopoulos K, Leandros E, Zografos G, Theodorou D. GERD-Related Questionnaires and Obese Population: Can They Really Reflect the Severity of the Disease and the Impact of GERD on Quality of Patients’ Life? Obes Surg. 2015;25:1882-1885.  [PubMed]  [DOI]
12.  Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch HA, Casson AG, Freedman ND. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One. 2014;9:e103508.  [PubMed]  [DOI]
13.  Shakhatreh MH, Duan Z, Avila N, Naik AD, Kramer JR, Hinojosa-Lindsey M, Chen J, El-Serag HB. Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol. 2015;13:280-286.  [PubMed]  [DOI]
14.  Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-120; quiz 1943.  [PubMed]  [DOI]
15.  Pandolfino JE. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355-1357.  [PubMed]  [DOI]
16.  de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol. 2008;103:1349-1354.  [PubMed]  [DOI]
17.  Seo AY, Shin CM, Kim N, Yoon H, Park YS, Lee DH. Correlation between hypersensitivity induced by esophageal acid infusion and the baseline impedance level in patients with suspected gastroesophageal reflux. J Gastroenterol. 2015;50:735-743.  [PubMed]  [DOI]
18.  Iannelli A, Martini F, Schneck AS, Gugenheim J. Twisted gastric sleeve. Surgery. 2015;157:163-165.  [PubMed]  [DOI]
19.  Sharma A, Aggarwal S, Ahuja V, Bal C. Evaluation of gastroesophageal reflux before and after sleeve gastrectomy using symptom scoring, scintigraphy, and endoscopy. Surg Obes Relat Dis. 2014;10:600-605.  [PubMed]  [DOI]
20.  Rebecchi F, Allaix ME, Giaccone C, Ugliono E, Scozzari G, Morino M. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260:909-14; discussion 914-5.  [PubMed]  [DOI]
21.  Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450-1456.  [PubMed]  [DOI]
22.  Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252:319-324.  [PubMed]  [DOI]
23.  Arias E, Martínez PR, Ka Ming Li V, Szomstein S, Rosenthal RJ. Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg. 2009;19:544-548.  [PubMed]  [DOI]
24.  Soricelli E, Iossa A, Casella G, Abbatini F, Calì B, Basso N. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg Obes Relat Dis. 2013;9:356-361.  [PubMed]  [DOI]
25.  Braghetto I, Csendes A, Korn O, Valladares H, Gonzalez P, Henríquez A. Gastroesophageal reflux disease after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech. 2010;20:148-153.  [PubMed]  [DOI]
26.  Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, Henriquez A. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg. 2010;20:357-362.  [PubMed]  [DOI]
27.  Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg. 2010;20:1-6.  [PubMed]  [DOI]
28.  Carter PR, LeBlanc KA, Hausmann MG, Kleinpeter KP, deBarros SN, Jones SM. Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2011;7:569-572.  [PubMed]  [DOI]
29.  Howard DD, Caban AM, Cendan JC, Ben-David K. Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients. Surg Obes Relat Dis. 2011;7:709-713.  [PubMed]  [DOI]
30.  Sieber P, Gass M, Kern B, Peters T, Slawik M, Peterli R. Five-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2011;10:243-249.  [PubMed]  [DOI]
31.  Gorodner V, Buxhoeveden R, Clemente G, Solé L, Caro L, Grigaites A. Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results. Surg Endosc. 2015;29:1760-1768.  [PubMed]  [DOI]
32.  Burgerhart JS, Schotborgh CA, Schoon EJ, Smulders JF, van de Meeberg PC, Siersema PD, Smout AJ. Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg. 2014;24:1436-1441.  [PubMed]  [DOI]
33.  DuPree CE, Blair K, Steele SR, Martin MJ. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg. 2014;149:328-334.  [PubMed]  [DOI]
34.  Sheppard CE, Sadowski DC, de Gara CJ, Karmali S, Birch DW. Rates of reflux before and after laparoscopic sleeve gastrectomy for severe obesity. Obes Surg. 2015;25:763-768.  [PubMed]  [DOI]
35.  Daes J, Jimenez ME, Said N, Daza JC, Dennis R. Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique. Obes Surg. 2012;22:1874-1879.  [PubMed]  [DOI]
36.  Daes J, Jimenez ME, Said N, Dennis R. Improvement of gastroesophageal reflux symptoms after standardized laparoscopic sleeve gastrectomy. Obes Surg. 2014;24:536-540.  [PubMed]  [DOI]
37.  Santonicola A, Angrisani L, Cutolo P, Formisano G, Iovino P. The effect of laparoscopic sleeve gastrectomy with or without hiatal hernia repair on gastroesophageal reflux disease in obese patients. Surg Obes Relat Dis. 2014;10:250-255.  [PubMed]  [DOI]
38.  Pallati PK, Shaligram A, Shostrom VK, Oleynikov D, McBride CL, Goede MR. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2014;10:502-507.  [PubMed]  [DOI]
39.  Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, Dimitriadis E, Stathaki M, Papadakis JA. Sleeve gastrectomy-a “food limiting” operation. Obes Surg. 2008;18:1251-1256.  [PubMed]  [DOI]
40.  Nocca D, Krawczykowsky D, Bomans B, Noël P, Picot MC, Blanc PM, de Seguin de Hons C, Millat B, Gagner M, Monnier L. A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg. 2008;18:560-565.  [PubMed]  [DOI]
41.  Petersen WV, Meile T, Küper MA, Zdichavsky M, Königsrainer A, Schneider JH. Functional importance of laparoscopic sleeve gastrectomy for the lower esophageal sphincter in patients with morbid obesity. Obes Surg. 2012;22:360-366.  [PubMed]  [DOI]
42.  Chopra A, Chao E, Etkin Y, Merklinger L, Lieb J, Delany H. Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure? Surg Endosc. 2012;26:831-837.  [PubMed]  [DOI]
43.  Rawlins L, Rawlins MP, Brown CC, Schumacher DL. Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis. 2013;9:21-25.  [PubMed]  [DOI]
44.  Del Genio G, Tolone S, Limongelli P, Brusciano L, D’Alessandro A, Docimo G, Rossetti G, Silecchia G, Iannelli A, del Genio A. Sleeve gastrectomy and development of “de novo” gastroesophageal reflux. Obes Surg. 2014;24:71-77.  [PubMed]  [DOI]
45.  Suter M, Dorta G, Giusti V, Calmes JM. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg. 2004;14:959-966.  [PubMed]  [DOI]
46.  Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol. 1999;94:2840-2844.  [PubMed]  [DOI]
47.  Curcic J, Roy S, Schwizer A, Kaufman E, Forras-Kaufman Z, Menne D, Hebbard GS, Treier R, Boesiger P, Steingoetter A. Abnormal structure and function of the esophagogastric junction and proximal stomach in gastroesophageal reflux disease. Am J Gastroenterol. 2014;109:658-667.  [PubMed]  [DOI]
48.  Gulkarov I, Wetterau M, Ren CJ, Fielding GA. Hiatal hernia repair at the initial laparoscopic adjustable gastric band operation reduces the need for reoperation. Surg Endosc. 2008;22:1035-1041.  [PubMed]  [DOI]
49.  Frezza EE, Barton A, Wachtel MS. Crural repair permits morbidly obese patients with not large hiatal hernia to choose laparoscopic adjustable banding as a bariatric surgical treatment. Obes Surg. 2008;18:583-588.  [PubMed]  [DOI]
50.  Soricelli E, Casella G, Rizzello M, Calì B, Alessandri G, Basso N. Initial experience with laparoscopic crural closure in the management of hiatal hernia in obese patients undergoing sleeve gastrectomy. Obes Surg. 2010;20:1149-1153.  [PubMed]  [DOI]
51.  Kim M, Navarro F, Eruchalu CN, Augenstein VA, Heniford BT, Stefanidis D. Minimally invasive Roux-en-Y gastric bypass for fundoplication failure offers excellent gastroesophageal reflux control. Am Surg. 2014;80:696-703.  [PubMed]  [DOI]
52.  Mejía-Rivas MA, Herrera-López A, Hernández-Calleros J, Herrera MF, Valdovinos MA. Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass. Obes Surg. 2008;18:1217-1224.  [PubMed]  [DOI]
53.  Merrouche M, Sabaté JM, Jouet P, Harnois F, Scaringi S, Coffin B, Msika S. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg. 2007;17:894-900.  [PubMed]  [DOI]
54.  Mion F, Dargent J. Gastro-oesophageal reflux disease and obesity: pathogenesis and response to treatment. Best Pract Res Clin Gastroenterol. 2014;28:611-622.  [PubMed]  [DOI]
55.  Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg. 2010;251:244-248.  [PubMed]  [DOI]
56.  De Groot NL, Burgerhart JS, Van De Meeberg PC, de Vries DR, Smout AJ, Siersema PD. Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2009;30:1091-1102.  [PubMed]  [DOI]
57.  Iannelli A, Kassir R, Schneck AS, Martini F, Gugenheim J. Hiatal hernia of the Roux-en-Y gastric bypass pouch 8 years after surgery. Obes Surg. 2014;24:1494-1496.  [PubMed]  [DOI]
58.  Soliman A. Laparoscopic Crural Repair With Simultaneous Sleeve Gastrectomy: way in Gastroesophageal Reflux Disease Treatment Associated With Morbid Obesity. J Minim Invasive Surg Sci. 2012;1:67-73.  [PubMed]  [DOI]
59.  Gibson SC, Le Page PA, Taylor CJ. Laparoscopic sleeve gastrectomy: review of 500 cases in single surgeon Australian practice. ANZ J Surg. 2015;85:673-677.  [PubMed]  [DOI]
60.  Watson DI, Thompson SK, Devitt PG, Smith L, Woods SD, Aly A, Gan S, Game PA, Jamieson GG. Laparoscopic repair of very large hiatus hernia with sutures versus absorbable mesh versus nonabsorbable mesh: a randomized controlled trial. Ann Surg. 2015;261:282-289.  [PubMed]  [DOI]
61.  Stiven PN, Hansen R, Richardson A, Leibman S, Smith GS. Postoperative Dysphagia in laparoscopic paraesophageal hernia repair: the effect of distal esophageal angulation. Surg Laparosc Endosc Percutan Tech. 2013;23:449-452.  [PubMed]  [DOI]
62.  Silecchia G, Iossa A, Cavallaro G, Rizzello M, Longo F. Reinforcement of hiatal defect repair with absorbable mesh fixed with non-permanent devices. Minim Invasive Ther Allied Technol. 2014;23:302-308.  [PubMed]  [DOI]
63.  Morales MP, Wheeler AA, Ramaswamy A, Scott JS, de la Torre RA. Laparoscopic revisional surgery after Roux-en-Y gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2010;6:485-490.  [PubMed]  [DOI]
64.  Cheung D, Switzer NJ, Gill RS, Shi X, Karmali S. Revisional bariatric surgery following failed primary laparoscopic sleeve gastrectomy: a systematic review. Obes Surg. 2014;24:1757-1763.  [PubMed]  [DOI]
65.  Silecchia G, De Angelis F, Rizzello M, Albanese A, Longo F, Foletto M. Residual fundus or neofundus after laparoscopic sleeve gastrectomy: is fundectomy safe and effective as revision surgery? Surg Endosc. 2014;Epub ahead of print.  [PubMed]  [DOI]
66.  Noel P, Nedelcu M, Nocca D, Schneck AS, Gugenheim J, Iannelli A, Gagner M. Revised sleeve gastrectomy: another option for weight loss failure after sleeve gastrectomy. Surg Endosc. 2014;28:1096-1102.  [PubMed]  [DOI]
67.  Coe PO, O’Reilly DA, Renehan AG. Excess adiposity and gastrointestinal cancer. Br J Surg. 2014;101:1518-131; discussion 1531.  [PubMed]  [DOI]